Actelion Ltd - Strategy and SWOT Report, is a source of comprehensive company data and information. The report covers the company’s structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.

Features:

• Detailed information on Actelion Ltd required for business and competitor intelligence needs
• A study of the major internal and external factors affecting Actelion Ltd in the form of a SWOT analysis
• An in-depth view of the business model of Actelion Ltd including a breakdown and examination of key business segments
• Intelligence on Actelion Ltd’s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
• News about Actelion Ltd, such as business expansion, restructuring, and contract wins
• Large number of easy-to-grasp charts and graphs that present important data and key trends

Highlights:

Actelion Ltd. (Actelion or “the company”) is a biopharmaceutical company focused on the discovery, development and commercialization of synthetic small-molecule drugs to address high unmet medical needs. The company primarily operates in the US and Europe. It is headquartered in Allschwil, Switzerland and employed 2,495 people as of June 2015. The company recorded revenues of CHF1,957.9 million ($2,140.9 million) during the financial year ended December 2014 (FY2014), an increase of 9.6% over FY2013. The operating profit of the company was CHF569.9 million ($623.2 million) in FY2014, an increase of 18.1% over FY2013. The net profit of the company was CHF593.8 million ($649.3 million) in FY2014, an increase of 31.2% over FY2013.

Reasons to Purchase:

• Gain understanding of Actelion Ltd and the factors that influence its strategies
• Track strategic initiatives of the company and latest corporate news and actions
• Assess Actelion Ltd as a prospective partner, vendor or supplier
• Support sales activities by understanding your customers' businesses better
• Stay up to date on Actelion Ltd’s business structure, strategy and prospects